[1] Zeldin DC, et al. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys. 1995 Jan 10;316(1):443-51. DOI:
10.1006/abbi.1995.1059[2] J H CAPDEVILA R C H J R Falck. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.[J]. Journal of Lipid Research, 2000, 41 2: 163-181.
[3] B E DAIKH. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9.[J]. Journal of Pharmacology and Experimental Therapeutics, 1994, 271 3: 1427-1433.
[4] YONGDE ZHANG. EET homologs potently dilate coronary microvessels and activate BK(Ca) channels.[J]. American journal of physiology. Heart and circulatory physiology, 2001, 280 6 1: H2430-40. DOI:
10.1152/ajpheart.2001.280.6.h2430[5] PATRICK Y.-K WONG J. R F Pi Shiang Lai. Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes[J]. Prostaglandins & other lipid mediators, 2000, 62 4: Pages 321-333. DOI:
10.1016/s0090-6980(00)00079-4[6] PENG SUN. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.[J]. Journal of The American Society of Nephrology, 2010, 21 10: 1667-1677. DOI:
10.1681/asn.2009111110[7] YINDI DING. The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the G(s) protein.[J]. Journal of Pharmacology and Experimental Therapeutics, 2014, 350 1: 14-21. DOI:
10.1124/jpet.114.214254